1. Immunology/Inflammation
  2. CD47
  3. KWAR 23

KWAR23 是一种 anti-human SIRPα 抗体。KWAR23 以高亲和力结合 human SIRPα,并破坏其与 CD47 的结合。KWAR23 与 tumor-opsonizing 抗体联合使用具有抗肿瘤活性,可用于研究癌症免疫疗法。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CAS No. : 2243227-60-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥6200
In-stock
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

KWAR23 is an anti-human SIRPα antibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research[1].

同型

Human IgG4 kappa

推荐同型对照抗体
种属

Human

体外研究
(In Vitro)

KWAR 23 (0-1 μM; 4 h) shows antitumor activity of human neutrophil and macrophage[1].
KWAR 23 induces human macrophage-dependent phagocytosis in human tumor-derived cell lines[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human macrophages and lymphoma cells
Concentration: 0-1 μM
Incubation Time: 4 h
Result: Showed human macrophages and neutrophils killing tumor cells following treatment with KWAR23.
体内研究
(In Vivo)

KWAR23 (intraperitoneal injection; 10 mg/kg; every other day; 21 d) exhibits effective antitumor activity in a human SIRPA knockin mouse model[1].
KWAR23 enhances neutrophil and macrophage antitumor activity in SRG Mice[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SIRPA knock-in mouse model injected with Burkitt’s lymphoma cells[1]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection; 10 mg/kg; every other day; 21 d
Result: Led to strong inhibition of tumor growth when combined with Rituximab.
CAS 号
性状

液体

颜色

Colorless to light yellow

运输条件

Shipping with dry ice.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Format
  • Human IgG4 kappa
Biological Activity
  • Immobilized SIRP alpha/CD172a Protein, Human can bind KWAR 23. The EC50 for this effect is 5.3 ng/mL.
纯度 & 产品资料

纯度: 99.80%

参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • 抗体抑制剂请问怎么灭菌呢?

    我们的抗体抑制剂产品本身就是无菌的,细胞实验可以用培养基稀释,动物实验可以用无菌 PBS 或者生理盐水稀释。

  • 抗体抑制剂的人源化,人鼠嵌合抗体有什么区别呢?

    人鼠嵌合抗体由鼠源可变区+人源恒定区组成,人源化约65%,免疫原性较高。人源化抗体仅保留鼠源CDR,其余为人源结构,人源化约90%,免疫原性较低。相比嵌合抗体,人源化抗体更接近人体抗体,安全性更高。

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
KWAR 23
目录号:
HY-P99175
需求量:
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》